This is an investigational study. Atezolizumab is FDA approved and commercially available for the treatment of several types of cancer, but not glioblastoma. Temozolomide is FDA approved and commercially available for the treatment of glioblastoma. The radiation therapy used in this study is being delivered using FDA-approved and commercially available methods.